DEFA14A: Disc Medicine, Inc. to Hold Annual Meeting on June 9, 2023

Sentiment:

Proxy Statement


Disc Medicine, Inc. will hold its annual stockholder meeting virtually on June 9, 2023, to vote on the election of directors and the ratification of the company's independent registered public accounting firm.

Summary

  • Disc Medicine, Inc. is holding its 2023 Annual Meeting of Stockholders on June 9, 2023.
  • The meeting will be held virtually at www.virtualshareholdermeeting.com/IRON2023 at 9:00 AM EDT.
  • Stockholders can vote on the proposals online at www.ProxyVote.com or by requesting a paper or email copy of the materials before May 26, 2023.
  • The voting items include the election of six directors and the ratification of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2023.

Sentiment

Score: 5

Explanation: The document is a neutral announcement of an upcoming annual meeting and standard voting matters.

Positives

  • Stockholders have multiple options for voting, including online and by requesting physical or electronic materials.
  • The meeting is being held virtually, which may increase accessibility for stockholders.

Industry Context

This is a standard annual meeting announcement, typical for publicly traded companies to fulfill their corporate governance obligations.

Stakeholder Impact

  • Shareholders are encouraged to vote on the proposals.
  • The outcome of the votes will determine the composition of the board of directors and the selection of the company's auditor.

Next Steps

  • Stockholders should review the proxy materials and vote on the proposals.
  • The company will hold the annual meeting on June 9, 2023.

Key Dates

DateDescription
May 26, 2023Deadline to request a paper or email copy of the meeting materials.
June 8, 2023Vote by 11:59 PM ET
June 9, 2023Date of the Annual Meeting at 9:00 AM EDT.
December 31, 2023Fiscal year end for which Ernst & Young LLP is being considered as the independent registered public accounting firm.

Keywords

Annual Meeting, Proxy Statement, Stockholders, Directors, Ernst & Young, Voting, Disc Medicine

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.